Game Plan Financial Advisors, LLC Windtree Therapeutics Inc Transaction History

Game Plan Financial Advisors, LLC

  • $172 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$0.16 - $281.7 $1,280 - $2.25 Million
8,000 Added 80.0%
18,000 $3,000
Q3 2022

Nov 02, 2022
BUY
$0.3 - $306.0 $3,000 - $3.06 Million
10,000 New
10,000 $3,000

Others Institutions Holding WINT

# of Institutions
2
Shares Held
4.09K
Call Options Held
0
Put Options Held
0
View Full List

About WINDTREE THERAPEUTICS INC

WINT Quotes by TradingView
  • Ticker WINT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,627,900
  • Market Cap $34M
  • Description
  • Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...
More about WINT
Track This Portfolio

Track Game Plan Financial Advisors, LLC Portfolio

Follow Game Plan Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Game Plan Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Game Plan Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email